Newsroom
Spotlight Story
UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA® (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS)
Read more
Press Releases
UCB data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership…
Read More
UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA® (certolizumab pegol) in pregnant…
Read More
UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S.…
Read More
Axios Names UCB a Winner of the Metro Atlanta Top Workplaces 2026 Award
Read More
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients…
Read More
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
Read MoreUCB Stories
UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI®…
Read More
Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps
Read More
Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis
Read More
UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States
Read More
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association…
Read More
